One man's opinion

The FDA's Oncologic Drugs Advisory Committee last week voted 8-to-1 in favor of approval of Ligand Pharmaceuticals Inc.'s Panretin alitretinoin topical gel for AIDS-related Kaposi's sarcoma. But the one negative vote was an interesting one, coming as it did from Michael Marco, the

Read the full 433 word article

How to gain access

Continue reading with a
two-week free trial.